Dr. Amin Malik Shah Abdul Majid is a renowned scientist specializing in botanical drugs, angiogenesis, cancer research, phytomedicine, and DNA-binding agents. Dr. Majid has made significant contributions to natural product-based therapeutics, anti-cancer drug discovery, and nanomedicine. Dr. Majid’s work has garnered over 3,500 citations, reflecting his impactful research in cancer biology, particularly the antiangiogenic and cytotoxic properties of natural compounds. His groundbreaking studies on essential oils, silver-based complexes, and xanthones have advanced innovative approaches to cancer treatment and translational medicine.

Dr. Fazlul Huq is a distinguished scholar with a career spanning over five decades, recognized for his contributions to cancer research and drug discovery. As an Associate Professor at the University of Sydney’s School of Medical Sciences, he spearheaded innovative research on tumor-active metal complexes, drug-DNA interactions, and synergistic drug combinations aimed at overcoming platinum resistance in ovarian and colorectal cancers. Dr. Huq earned his PhD in Chemical Crystallography from University College London and held several prestigious roles, including ARC Postdoctoral Research Fellow and Group Leader of the Biomedical Science Cancer Research Group. He has authored over 312 peer-reviewed publications, accumulated more than 3,015 citations, and successfully supervised 26 PhD and 5 master’s students. A member of esteemed organizations such as the Royal Society of Chemistry, Dr. Huq’s legacy is defined by impactful teaching, pioneering research, and influential mentorship, leaving an indelible mark on the global scientific community.

 Prof. Dr. Aman Shah Abdul Majid, FRSB, is a distinguished academic and researcher in the Faculty of Medicine at the Centre for Angiogenesis and Natural Product Research. His work focuses on clinical research, natural product screening, angiogenesis, cell signaling, and neuroprotection. Prof Aman is a multidisciplinary clinician-scientist trained in pharmacy, medicine, and visual neuroscience. He earned postgradute degree from the University of Otago in Pharmaceutical Sciences, M.B.Ch.B. in Basic Pre-Clinical Sciences, Clinical Medicine and Surgical Sciences from the University of Sheffield, and Ph.D. in Ophthalmology from the University of Oxford, specializing in experimental pharmacotherapeutics and optic nerve neurodegeneration.

Professor Dr. Abdul Kadir Othman is a distinguished scholar at the Faculty of Business and Management, Universiti Teknologi MARA Malaysia. Specializing in organizational psychology, customer service management, and Islamic marketing, he has made significant contributions to understanding leadership styles, employee engagement, and customer satisfaction. His research spans diverse topics, including loyalty programs, service recovery, and the intersection of Islamic principles with modern business practices. A prolific author, Professor Othman has numerous high-impact publications that explore innovative frameworks for improving organizational performance and customer experience. His work combines academic rigor with practical insights, influencing both academia and industry practices.

Dr. Armaghan Shafaei is a Chemistry Lecturer at the School of Science, Edith Cowan University (ECU). Her expertise lies in phytochemistry, analytical chemistry, and toxicology, focusing on the medicinal properties of plant extracts and their applications in chronic disease prevention and cancer therapy. Dr. Shafaei's notable contributions include studies on Ficus deltoidea and Mesua ferrea, exploring their genotoxicity, anticancer, and antioxidant potentials. His work also advances analytical techniques, such as LC-MS/MS, for biomarker quantification in clinical research. With over 20 high-impact publications, Dr. Shafaei continues to innovate in natural product research and its integration into therapeutic strategies.

Emeritus Professor Chris Parish is an immunologist and leader of the Cancer and Vascular Biology Group at ANU's John Curtin School of Medical Research. He earned his PhD at The Walter & Eliza Hall Institute and has spent over 35 years advancing immunology. In the 1970s, he was the first to demonstrate the antagonistic relationship between cell-mediated immunity and antibody formation, a discovery central to the Th1/Th2 paradigm. His work on heparan sulfate and heparanase has led to the development of novel anti-cancer therapies, including PI-88. In 2005, he received the prestigious Ramaciotti Medal for Excellence in Biomedical Research for his groundbreaking contributions.

Dr. Erma Setiawati is an accomplished academic affiliated with Universitas Muhammadiyah Surakarta. Her expertise spans accounting, finance, and corporate governance. She has significantly contributed to scholarly discourse through impactful publications like "Deteksi Fraudulent Financial Reporting Menggunakan Analisis Fraud Pentagon" and studies on profitability, financial performance, and good corporate governance. Her interdisciplinary work also explores topics in public health and local economic development, such as the socio-economic dynamics of batik enterprises in Indonesia. Dr. Setiawati’s research has been widely cited, showcasing her influence in academia. She actively engages in advancing accounting and management practices in both conventional and Islamic financial systems.

Dr. Loiy Esir Ahmed Hassan is a Scientist in cancer biology, drug discovery, tumor angiogenesis, and preclinical pharmacology. His innovative work bridges the gap between natural product-based therapeutics and cancer therapy. With over 1,500 citations, Dr. Hassan has made significant strides in understanding the anticancer and anti-inflammatory properties of natural compounds, including cucurbitacins and essential oils. His research explores molecular mechanisms of tumor suppression, targeting pathways such as angiogenesis and apoptosis, advancing novel chemotherapeutic strategies. Dr. Hassan’s work continues to impact cancer treatment and translational medicine globally.

Dr. Mohamed Khadeer Ahamed is a Clinical Research Associate II at CTI Clinical Trial and Consulting Services in Sydney, Australia, with over 15 years of experience in clinical research. A biochemist and pharmacologist, his expertise spans oncology, diabetes, and preclinical toxicology studies. Dr. Ahamed has contributed significantly to cancer biology, angiogenesis, and experimental pharmacology, focusing on natural products like Aquilaria crassna and Ficus deltoidea. He holds a PhD in Pharmacology from Kuvempu University and has authored several key papers on the anticancer, antioxidant, and antimicrobial properties of natural compounds, driving innovation in drug development and cancer research.

Dr. Muhammad Adnan Iqbal is an Associate Professor in the Department of Chemistry at the University of Agriculture Faisalabad. His research spans organometallics, coordination chemistry, and medicinal and environmental chemistry. Dr. Iqbal has made significant contributions to the development of silver-based complexes with anticancer, antioxidant, and antimicrobial properties. His studies also focus on the synthesis of novel metal complexes for biomedical applications, particularly in cancer treatment. Dr. Iqbal has co-authored over 80 publications in leading journals, advancing the field of coordination chemistry and its potential applications in medicine and environmental science.

Dr. Muhammad Asif, an accomplished pharmacologist, serves as an Associate Professor in the Department of Pharmacology, Faculty of Pharmacy, The Islamia University of Bahawalpur, Pakistan. A Higher Education Commission (HEC)-approved supervisor, he has a PharmD and MPhil in Pharmacology from The Islamia University of Bahawalpur and a PhD in Pharmacology from Universiti Sains Malaysia. Dr. Asif has expertise in pharmacological screening, bioactive compound isolation, and nanoformulations, supported by extensive experience with advanced instrumentation. With 104 research articles, 2,068 citations, and multiple national and international awards, his work exemplifies leadership in drug discovery and herbal medicine research.

Dr. Simin Li is a Professor at the Stomatological Hospital, Southern Medical University, specializing in dentistry and molecular biology. Her research focuses on oral squamous cell carcinoma, periodontitis, and the role of long non-coding RNAs (lncRNAs) in these conditions. Dr. Li has contributed to significant studies exploring the molecular mechanisms underlying oral diseases, antimicrobial peptides, and cancer progression. She has co-authored numerous high-impact papers, including research on miRNA networks in periodontitis and oral cancer, and has become a key figure in advancing diagnostic and therapeutic strategies in oral health.

Dr. Vishwanadham Mandala is a leading expert in big data, AI, machine learning, and data engineering, with significant contributions to data science and analytics. Currently serving as Enterprise Architect - Data at Cummins, he focuses on AI-driven solutions in automotive safety, manufacturing, and predictive maintenance. Dr. Mandala has authored numerous papers on topics like AI-based recommendation models, predictive failure analytics, and real-time engine failure prediction. His research also explores big data lake houses, data integration, and optimizing supply chains, making him a recognized figure in the field of advanced data analytics and artificial intelligence.

Dr. Ali F. Jameel is an Assistant Professor at the Faculty of Education and Arts, Sohar University, Sultanate of Oman. His research expertise lies in fuzzy mathematics, differential equations, and numerical and approximation methods. Dr. Jameel has made significant contributions to solving complex mathematical problems, including fuzzy differential equations, boundary value problems, and delay differential equations, often employing innovative techniques like homotopy and numerical analysis. With numerous publications in high-impact journals, his work addresses theoretical advancements and practical applications in physics and engineering. Dr. Jameel is recognized for his collaborative and analytical approach, advancing computational mathematics in diverse domains.

Dr. Fouad Saleh Resq Al-Suede is a Scientist in the field of pharmacology, experimental medicine, and advanced nutraceuticals. His work focuses on antiangiogenesis, cancer pathways, and the therapeutic potential of natural products. Dr. Al-Suede has made significant contributions to isolating and characterizing bioactive compounds from medicinal plants such as Kaempferia galanga and Orthosiphon stamineus. His research has elucidated molecular mechanisms underlying anti-inflammatory, anticancer, and pro-apoptotic effects, advancing innovative strategies for cancer treatment. With numerous high-impact publications, Dr. Al-Suede continues to bridge pharmacology and natural medicine, fostering novel approaches in oncology and precision therapeutics.

Dr. Mahfoudh Abdulghani is an academic and researcher and focuses on the pharmacology of the female reproductive system, with extensive research on medicinal plants and their therapeutic applications. Dr. Abdulghani has published numerous studies, including on the effects of Eurycoma longifolia and Mentha spicata in reproductive health, as well as on the perceptions of students regarding generic medicines. His contributions span areas such as cancer therapy, antimicrobial activity, and environmental health, making him a leader in his field.

Dr. Majed Ahmed Al-Mansoub is a university lecturer at the Faculty of Medicine and Health Sciences, Universiti Malaysia Sarawak. His research interests include applied biochemistry, pharmacology, toxicology, pharmacognosy, and phytochemical screening. Dr. Al-Mansoub has contributed extensively to studies on the anticancer properties of medicinal plants, such as Illicium verum and Garcinia atroviridis, as well as evaluating the toxicity and therapeutic effects of plant extracts. He has also focused on the molecular mechanisms behind cell death, anti-inflammatory activities, and cardiovascular protection. His work aims to enhance the understanding of natural products for drug development and disease prevention.

Dr. Malek Zihlif, a faculty member in the Department of Pharmacology at the University of Jordan, specializes in pharmacogenomics, cancer biology, and drug resistance. He investigated the genetic and molecular mechanisms underlying cancer progression, with significant contributions to understanding doxorubicin resistance and hypoxia-induced gene expression in breast cancer. Dr. Zihlif has explored innovative anticancer therapies, including bioactive compounds and liposomal drug delivery systems, earning widespread recognition with nearly 200 citations for his pioneering study on MCF7 cell lines. A prolific researcher, he actively collaborates on projects advancing personalized medicine and novel therapeutic strategies in oncology and pharmacology.

Dr. Md Fakruddin is an Associate Professor at the Department of Biochemistry & Microbiology, North South University, Dhaka, Bangladesh. His research spans hematopoiesis, stem cell biology, mitochondrial biology, tRNA modification, and microbiology. Dr. Fakruddin has made significant contributions to nanobiotechnology, biosurfactants, and alternative nucleic acid amplification methods. His work also includes antimicrobial and antioxidant activity studies of probiotics, along with predictive microbiology in food safety. With a focus on microbial community diversity and mitochondrial diseases, Dr. Fakruddin is dedicated to advancing our understanding of biotechnology's potential in medicine and environmental applications.

Dr. Chern Ein Oon is a molecular Oncologist at INFORMM, Universiti Sains Malaysia, specializing in targeted cancer therapies, Notch signaling, and tumor angiogenesis. Her impactful research, reflected in over 1,000 citations for her seminal work on molecular therapies, has advanced the understanding of cancer mechanisms and therapeutic strategies. Dr. Oon’s expertise extends to sirtuins and bioactive compound analysis, contributing to innovative approaches in combating tumorigenesis and metastasis. With a prolific academic record, she has co-authored groundbreaking studies on exosomal signaling, VEGF resistance, and apoptosis modulation, establishing herself as a leader in precision oncology and translational cancer research.

Dr. Saad Sabbar Dahham is an Associate Professor, at the University of Technology and Applied Sciences, Rustaq, Oman, specializing in cancer biology and microbiology. His work focuses on natural compounds with anticancer, antimicrobial, and antioxidant properties, particularly from Aquilaria crassna, Punica granatum, and Terfezia claveryi. Dr. Dahham's research has significantly contributed to understanding bioactive essential oils and their therapeutic applications, including β-caryophyllene's potential in cancer treatment. With a robust publication record in leading journals, his studies bridge molecular biology, pharmacology, and traditional medicine, advancing innovative strategies for cancer prevention and treatment through natural and sustainable approaches.

Dr. Sultan Ayesh Mohammed Saghir is an associate professor in the Department of Medical Analysis at Princess Aisha Bint Al-Hussein College of Nursing and Medical Sciences. His research primarily focuses on hematology, blood banking, and natural products. Dr. Saghir has made significant contributions to the understanding of oxidative stress, inflammation, and the therapeutic potential of various natural compounds. His studies include the effects of galangin, formononetin, and Averrhoa carambola on liver injury, kidney protection, and antimicrobial activity. He is also involved in exploring prebiotics' role in controlling Salmonella in poultry and improving heat stress resistance in livestock.

Dr. Tímea Téglás is a Senior Research Fellow at the Research Center for Molecular Exercise Science, Hungarian University of Sports Science, Hungary. She holds a Ph.D. in Sport Sciences and an M.Sc. in Molecular Genetics from the University of Debrecen. With extensive postdoctoral experience at the University of Miami, her research integrates molecular biology, neuroinflammation, and exercise physiology. Dr. Téglás has published widely in high-impact journals and received several awards, including the Lois Pope Fellowship and Poster Award at the University of Miami. She actively contributes to editorial boards and scientific societies, advancing translational health and sport science research globally.

Dr. William Feeman, MD, is the Principal Investigator of The Bowling Green Study, focusing on lipid metabolism, atherosclerosis, and metabolic diseases. With over 100 publications and a significant research impact, Dr. Feeman's work explores key risk factors for atherothrombotic disease (ATD), including the Cholesterol Retention Fraction's predictive power compared to LDL-cholesterol. His studies emphasize the importance of lipid management in disease prevention and treatment, including long-term statin therapy outcomes. Dr. Feeman’s expertise spans insulin resistance, glucose metabolism, hypertension, and diabetes, making him a prominent figure in cardiovascular and metabolic disease research.

Dr. Yam Mun Fei, is an Associate Professor at the School of Pharmaceutical Sciences, Universiti Sains Malaysia, in pharmacology. His research focuses on pain regulation, anti-inflammatory agents, antioxidant activity, and natural product pharmacology. Dr. Yam has made significant contributions to understanding bioactive compounds from plants such as Orthosiphon stamineus and Gynura procumbens, advancing their applications in diabetes, inflammation, and hepatoprotection. His impactful studies, often cited globally, include groundbreaking insights into the pharmacological properties of flavonoids and terpenoids. Dr. Yam’s work bridges traditional medicinal knowledge with modern drug discovery, solidifying his role in advancing pharmaceutical sciences.

Agus Dwianto is a lecturer and researcher specializing in innovation analysis, sustainability, and corporate governance. Affiliated with Universitas Muhammadiyah Surakarta, he actively contributes to academic discourse through Scopus and Web of Science-indexed publications. His work explores diverse themes, including environmental accounting, fraud detection, board gender diversity, and Islamic economic empowerment. Agus’s research spans global issues such as sustainable business practices, digital entrepreneurship, and macroeconomic impacts of international trade regulations. With notable studies on sustainability and financial performance, he provides valuable insights into aligning corporate governance with environmental and social responsibilities, promoting ethical practices and long-term value creation.

Dr. Ahmad M. Abdel-Mageed is a distinguished researcher at the College of Science, Northern Border University, KSA. Specializing in innate immunity, immunology, physiology, and animal science, his impactful work explores avian β-defensins, immunomodulation, and oxidative stress mitigation. Notable publications include studies on β-defensins' expression in hens and the protective roles of folic acid and melatonin in diabetic nephropathy. His interdisciplinary research spans from poultry immunology to the therapeutic potential of medicinal plants and nanotechnology. With over 90 citations, Dr. Abdel-Mageed contributes significantly to advancing knowledge in immunology, animal health, and physiological responses to environmental and pathological stressors.

Md. Sakil Amin is a researcher at the University of South Florida, specializing in nanotechnology, drug delivery, and gene delivery. His research focuses on innovative therapeutic approaches for oxidative stress, inflammation, and fibrosis. Key studies include the protective effects of Baccaurea ramiflora fruit peel powder and Mimosa pudica leaf extract in models of oxidative stress and fibrosis, and the cardioprotective properties of black seed supplementation. He has also contributed to pharmaceutical analytical chemistry, notably in developing a stability-indicating RP-HPLC method for ophthalmic formulations. His work bridges pharmacological innovation with nanotechnology to advance drug and gene delivery systems for enhanced therapeutic efficacy.

Dr. Miaoyun Zhao is a Senior Postdoctoral Fellow at The Wistar Institute, specializing in HIV/SIV pathogenesis, vaccine development, and host–pathogen interactions. She earned her Ph.D. in Biochemistry from the University of Nebraska–Lincoln, where she investigated metabolic regulation in adipose and hepatic tissues. Her postdoctoral work spans HIV–MTB co-infection models, immune cell dynamics in humanized mice, and cutting-edge spatial transcriptomics using 10X Genomics and Akoya platforms. Dr. Zhao has authored numerous peer-reviewed publications and contributes extensively as a scientific reviewer. Her research integrates virology, immunology, and advanced molecular methods to advance therapeutic and vaccine strategies.

Research area: HIV/SIV pathogenesis; Vaccine development; Spatial transcriptomics; Host–pathogen interactions; Immunometabolism; Humanized mouse models

Dr. Mohammad Mamun Alam is a Postdoctoral Fellow in the Division of Infectious Disease at Icahn School of Medicine, Mount Sinai Hospital. His research focuses on virology, immunology, and molecular microbiology. Dr. Alam has contributed to the development of novel multi-epitope vaccines, including work on the Nipah Virus and SARS-CoV-2 variants. He has also conducted research on immune responses to COVID-19 vaccines in Bangladesh and studied antiviral activities against Dengue Virus. His expertise extends to molecular epidemiology, multidrug-resistant tuberculosis detection, and HIV-1 inhibition. Dr. Alam’s work has significantly advanced our understanding of infectious diseases and immune responses.

Dr. Gu Panpan received her Ph.D. in Biology and Medicine from Fudan University, China, where she also earned her Master’s in Biochemistry and Molecular Biology. She specializes in translational biomedical research with a focus on antimicrobial diagnostics, cancer genomics, and regulatory sciences. Dr. Gu’s contributions include developing CRISPR-based diagnostic platforms and investigating the role of TET2 mutations in breast cancer. She has also completed advanced training at Peking University in drug development and regulatory sciences. Currently, Dr. Gu is engaged in innovative research connecting molecular biology with clinical applications to improve patient outcomes and therapeutic strategies.

Research area: CRISPR diagnostics, cancer genomics, TET2 mutations, breast cancer, translational research, molecular biology, antimicrobial resistance, drug development, regulatory sciences, biomolecular tools.

Dr. SK. Chand Basha, FTE, serves as an Assistant Professor in the Department of Zoology at Andhra Loyola College (Autonomous), India. His research spans neurosciences, microbial technology, and bioinformatics, with a strong focus on Alzheimer's disease, mangrove ecosystems, and microbial bioactives. Dr. Basha’s contributions include insights into the role of TREM2 in Alzheimer's pathophysiology, computational docking studies for therapeutic applications, and the bioactivity of mangrove-derived actinomycetes. His interdisciplinary work extends to sustainable development, geopolitical studies, and renewable energy. An accomplished academic, Dr. Basha has published extensively, offering valuable contributions to both environmental conservation and medical science research.

Dr. Yasser Tabana is working as biochemist at the University of Alberta, specializing in cancer immunotherapy and biochemistry. His research focuses on the molecular mechanisms underlying cancer progression, emphasizing natural compounds' anticancer, antioxidant, and antimicrobial properties. Dr. Tabana has contributed significantly to the development of small molecule inhibitors targeting PD-L1, a crucial immune checkpoint in cancer therapy. His work also explores the therapeutic potential of essential oils and plant extracts in treating cancer and other diseases. With numerous publications and citations, Dr. Tabana’s research continues to impact the fields of immunotherapy and drug discovery.

Qi Liu is a researcher at Johns Hopkins University specializing in heart failure, aging, and muscle atrophy. Her work focuses on the molecular mechanisms underlying muscle wasting, particularly the roles of non-coding RNAs and the PPARγ/miR-29b signaling pathway. She has contributed to identifying novel therapeutic strategies, including small-molecule inhibitors and exercise interventions, to prevent or reverse muscle atrophy. Her studies integrate molecular biology, translational research, and exercise physiology to address clinical challenges associated with cardiac and age-related muscle degeneration. Qi Liu has published extensively in high-impact journals, advancing understanding of muscle biology and potential therapies for muscle loss.

Research area: Muscle Atrophy, Heart Failure, Aging, Exercise Therapy, Non-coding RNA, miR-29b

Wendi Ma, M.S., B.S. Pharm., is a translational scientist and PhD candidate at the University of Miami Miller School of Medicine specializing in oncology, pharmacology, neuroscience, and immunology. With over a decade of experience spanning drug development, molecular techniques, in vivo pharmacology, and regulatory strategy, she integrates scientific rigor with compliance-driven decision-making. Her work includes nanoparticle-based therapeutics, epigenetic drug mechanisms, AI applications in clinical reporting, and neuro-immunological pharmacology. Wendi has contributed to peer-reviewed publications, book chapters, and national conference presentations, and is committed to advancing clinical development, medical affairs, and evidence-based therapeutic innovation.

Research area: Oncology; Pharmacology; Nanomedicine; Neuroscience; Immunology; Clinical Development

Dr. Abdulsalam Ali Abuelsamen, a distinguished Medical Physics expert at Aqaba University of Technology, focuses on advancing medical nanotechnology, photodynamic therapy, and radiography applications. His pioneering research integrates nanomaterials, such as ZnO nanorods and silica nanoparticles, for use in photodetectors, biosensors, and cancer therapies. With extensive contributions in nanostructure synthesis and characterization, he has significantly impacted UV detection, hydrogen sensing, and photodynamic treatment for osteosarcoma and bladder cancer. Dr. Abuelsamen’s interdisciplinary approach bridges material science and medical applications, driving innovations in theranostic technologies and personalized medicine. His work reflects a commitment to sustainable and impactful advancements in healthcare.

Dr. Bhisma Narayan Ratha, Assistant Professor at Centurion University of Technology and Management, is a leading researcher in protein biochemistry, biophysics, and phytochemistry. His groundbreaking work focuses on understanding amyloid fibrillation, particularly in insulin and α-synuclein, with implications for neurodegenerative diseases and diabetes. Dr. Ratha's contributions to the study of protein aggregation mechanisms, membrane interactions, and therapeutic peptide development have garnered significant recognition. His innovative approaches to inhibiting amyloid formation and biofilm growth highlight his interdisciplinary expertise in nanomedicine and therapeutic biochemistry. Through his prolific publications, Dr. Ratha has advanced the fields of molecular biology and translational medicine.

Dr. Hayder B. Sahib is a Professor specializing in pharmacology and toxicology at Al-Nahrain University, Iraq. His research explores the pharmacological potential of medicinal plants, focusing on their anti-angiogenic, antioxidant, and anti-proliferative properties. He has extensively studied Orthosiphon stamineus, Vitex agnus-castus, and Phoenix dactylifera for their therapeutic applications in cancer, hyperlipidemia, and toxicity management. Professor Sahib's work bridges traditional medicine and modern pharmacological approaches, contributing significantly to understanding natural compounds in combating diseases. His publications have been widely cited, reflecting his impact on advancing natural product pharmacology and its application in treating complex health conditions.

Dr. Md Nafiujjaman is a prominent researcher in nanomedicine, theranostics, and drug delivery systems. As a Research Associate at Michigan State University, his work focuses on developing cutting-edge contrast agents and nanotechnology-driven therapeutic strategies for precision medicine. Dr. Nafiujjaman has over 20 high-impact publications and 1,700 citations, reflecting his contributions to advanced biomedical applications such as graphene quantum dots, photo-chemo theranostics, and exosome-based diagnostics. His research bridges molecular nanotechnology with clinical innovation, offering transformative solutions in imaging, cancer therapy, and biomarker discovery. Recognized globally, Dr. Nafiujjaman’s work advances the field of nanomedicine and translational healthcare.

Dr. Mostafa Alamholo is a researcher specializing in biotechnology and bioinformatics, with a strong focus on natural product research and plant-derived bioactives. His work explores the antibacterial, antioxidant, and phytochemical properties of various medicinal plants, including Citrus medica, Thymus spp., and Pistacia atlantica. He has contributed to understanding molecular mechanisms of stress tolerance in crops like barley (Hordeum vulgare), combining transcriptomic and meta-analytical approaches. Dr. Alamholo’s studies are widely recognized for their application in pharmacology, sustainable agriculture, and microbial resistance. Despite limited affiliation visibility, his interdisciplinary work addresses critical challenges in microbiology and medicinal plant research.

Professor Dr. Mouayed A. Hussein is a distinguished academic in the fields of photochemistry, inorganic chemistry, and medicinal chemistry. He holds a professorship at the University of Basrah, Iraq, and has made significant contributions to the synthesis and characterization of metal complexes with biological applications. His research focuses on the anticancer, pro-apoptotic, and anti-metastatic properties of metal-based complexes, particularly binuclear silver(I)–N-heterocyclic carbene complexes. Prof. Hussein's work has resulted in multiple publications in high-impact journals, highlighting his expertise in DNA binding, cleavage, and antitumor activities. He continues to explore innovative approaches in the development of therapeutic agents.

Dr. Muhammed Ihsan Han, a faculty member at Erciyes University, specializes in medicinal chemistry, focusing on the design and synthesis of bioactive compounds. His research primarily explores hydrazide-hydrazones, thiosemicarbazides, and naproxen derivatives for their anticancer, antimicrobial, and anti-inflammatory properties. Dr. Han’s innovative studies integrate molecular docking, in vitro, and in vivo evaluations, advancing targeted therapies, particularly for breast and colon cancer. With over 100 citations for his impactful publications, he contributes significantly to medicinal chemistry, emphasizing sustainable drug discovery. His dedication to interdisciplinary approaches and novel therapeutic agents makes him a leading researcher in pharmacological innovation.

Dr. Nozlena Abdul Samad, is a Associate Professor at Universiti Sains Malaysia, specializes in cancer research, angiogenesis, and phytomedicine. Her pioneering work explores the anticancer potential of natural compounds, particularly through innovative drug delivery systems and nanomedicine. Dr. Samad’s notable studies on Moringa oleifera and Zerumbone have elucidated their mechanisms in suppressing tumor growth and angiogenesis. With a strong focus on the biomedical applications of plant-based therapies, she bridges traditional medicine with modern therapeutic advancements. Renowned for her systematic reviews and translational research, Dr. Samad’s contributions have significantly enriched the field of phytopharmacology and novel anticancer strategies.

Dr. Sadia Sarwar is a lecturer at Riphah International University, specializing in pharmacognosy. She holds a Ph.D. and M.Phil. in Plant Physiology, with a strong foundation in molecular biology and biotechnology. Her research expertise includes DNA extraction, gel electrophoresis, PCR, cell culture, and tissue culture techniques. Dr. Sarwar is actively involved in exploring plant-based compounds for medicinal purposes, contributing to the field with her knowledge of DNA isolation and purification. With a focus on advancing pharmacognosy, her work aims to bridge plant sciences and modern therapeutic applications. She has published several research articles and continues to collaborate within the scientific community.

Dr. Sakina Ruhi is a lecturer and biochemist with a PhD in Biomedical Sciences from the Management and Science University (MSU), Malaysia (2024). Holding an MD in Biochemistry (2010) and an Executive MBA in Healthcare Management (2016), she integrates academic excellence with administrative expertise. She serves as a faculty member at MSU, where she leads teaching initiatives in biochemistry, chemical pathology, and natural product research. A prolific researcher with 26 Scopus-indexed publications, her work spans lipid metabolism, natural product formulations, and healthcare management. Dr. Ruhi is a life member of the Association of Biochemistry of India and the Telangana State Medical Council.

Dr. Yaser Aly Ammar, MD, is a distinguished nephrologist at the Medical Research Institute, Alexandria University. With expertise in nephrology, internal medicine, and human biology, Dr. Ammar’s research focuses on bioinformatics, computational biology, and renal biopsy techniques. His scholarly contributions, encompassing 25 publications with over 4,000 reads and numerous citations, underscore his commitment to advancing kidney health and innovative diagnostic approaches. Dr. Ammar combines clinical expertise with cutting-edge bioscience methodologies, making significant strides in understanding renal diseases and improving patient outcomes. His work continues to inspire collaborations within the global scientific community.